Peptidergic induction of endothelin 1 and prostanoid secretion in human cerebromicrovascular endothelium.
Spatz
M
M
National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892.
Stanimirovic
D B
DB
Bacic
F
F
Uematsu
S
S
Bembry
J
J
McCarron
R M
RM
D000804:Angiotensin II / Q000494:pharmacology*; D001127:Arginine Vasopressin / Q000494:pharmacology*; D001921:Brain / Q000098:blood supply*; D002478:Cells, Cultured; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology; D016232:Endothelins / Q000096:biosynthesis* / Q000378:metabolism; D004730:Endothelium, Vascular / Q000187:drug effects / Q000378:metabolism*; D006801:Humans; D016859:Lipoxygenase Inhibitors / Q000494:pharmacology; D008833:Microcirculation / Q000187:drug effects / Q000378:metabolism; D010741:Phospholipases A / Q000037:antagonists & inhibitors; D011453:Prostaglandins / Q000096:biosynthesis* / Q000378:metabolism
D016861:Cyclooxygenase Inhibitors; D016232:Endothelins; D016859:Lipoxygenase Inhibitors; D011453:Prostaglandins; D000804:Angiotensin II; D001127:Arginine Vasopressin; D010741:Phospholipases A